These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37139287)

  • 21. Trends and Patterns of Opioid Analgesic Prescribing: Regional and Rural-Urban Variations in Kentucky From 2012 to 2015.
    Luu H; Slavova S; Freeman PR; Lofwall M; Browning S; Bush H
    J Rural Health; 2019 Jan; 35(1):97-107. PubMed ID: 29664203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buprenorphine Prescribing Characteristics Following Relaxation of X-Waiver Training Requirements.
    Christine PJ; Chahine RA; Kimmel SD; Mack N; Douglas C; Stopka TJ; Calver K; Fanucchi LC; Slavova S; Lofwall M; Feaster DJ; Lyons M; Ezell J; Larochelle MR
    JAMA Netw Open; 2024 Aug; 7(8):e2425999. PubMed ID: 39102264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A survey of barriers and facilitators to the adoption of buprenorphine prescribing after implementation of a New Jersey-wide incentivized DATA-2000 waiver training program.
    Nyaku AN; Zerbo EA; Chen C; Milano N; Johnston B; Chadwick R; Marcello S; Baston K; Haroz R; Crystal S
    BMC Health Serv Res; 2024 Feb; 24(1):179. PubMed ID: 38331802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder.
    Haffajee RL; Lin LA; Bohnert ASB; Goldstick JE
    JAMA Netw Open; 2019 Jun; 2(6):e196373. PubMed ID: 31251376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. County-level neonatal opioid withdrawal syndrome rates and real-world access to buprenorphine during pregnancy: An audit ("secret shopper") study in Missouri.
    Bedrick BS; Cary C; O'Donnell C; Marx C; Friedman H; Carter EB; Raghuraman N; Stout MJ; Ku BS; Xu KY; Kelly JC
    Drug Alcohol Depend Rep; 2024 Mar; 10():100218. PubMed ID: 38380272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescribing Practices of Rural Physicians Waivered to Prescribe Buprenorphine.
    Andrilla CHA; Coulthard C; Patterson DG
    Am J Prev Med; 2018 Jun; 54(6 Suppl 3):S208-S214. PubMed ID: 29779544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prior use of medications for opioid use disorder in ED patients with opioid overdose: prevalence, misuse and overdose severity.
    Shastry S; Nobel I; Allen LR; Richardson LD; Vidal K; Manini AF
    Am J Emerg Med; 2022 Jan; 51():114-118. PubMed ID: 34735968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion.
    Saloner B; Levin J; Chang HY; Jones C; Alexander GC
    JAMA Netw Open; 2018 Aug; 1(4):e181588. PubMed ID: 30646116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From policy to practice: Pilot program increases access to medication for opioid use disorder in rural Colorado.
    Sorrell TR; Weber M; Alvarez A; Beste N; Hollins U; Amura CR; Cook PF
    J Subst Abuse Treat; 2020 Jul; 114():108027. PubMed ID: 32527514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. County-level sociodemographic differences in availability of two medications for opioid use disorder: United States, 2019.
    Corry B; Underwood N; Cremer LJ; Rooks-Peck CR; Jones C
    Drug Alcohol Depend; 2022 Jul; 236():109495. PubMed ID: 35605533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in buprenorphine prescribing readiness among primary care professionals with and without X-waiver training in the US.
    Franz B; Dhanani LY; Hall OT; Brook DL; Simon JE; Miller WC
    Harm Reduct J; 2023 Dec; 20(1):180. PubMed ID: 38129903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder.
    Andrilla CHA; Coulthard C; Larson EH
    Ann Fam Med; 2017 Jul; 15(4):359-362. PubMed ID: 28694273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
    Jones CM; McCance-Katz EF
    Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statewide opioid prescriptions and the prevalence of adolescent opioid misuse in Ohio.
    McKnight ER; Bonny AE; Lange HLH; Kline DM; Abdel-Rasoul M; Gay JR; Matson SC
    Am J Drug Alcohol Abuse; 2017 May; 43(3):299-305. PubMed ID: 27646841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations between implementation of Project Lazarus and opioid analgesic dispensing and buprenorphine utilization in North Carolina, 2009-2014.
    Alexandridis AA; Dasgupta N; McCort AD; Ringwalt CL; Rosamond WD; Chelminski PR; Marshall SW
    Inj Epidemiol; 2019 Jan; 6(1):2. PubMed ID: 30663005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio.
    Molfenter T; Sherbeck C; Zehner M; Quanbeck A; McCarty D; Kim JS; Starr S
    Subst Abuse Treat Prev Policy; 2015 Mar; 10():13. PubMed ID: 25884206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Buprenorphine prescription dispensing rates and characteristics following federal changes in prescribing policy, 2017-2018: A cross-sectional study.
    Roehler DR; Guy GP; Jones CM
    Drug Alcohol Depend; 2020 Aug; 213():108083. PubMed ID: 32505044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variations in national availability of waivered buprenorphine prescribers by racial and ethnic composition of zip codes.
    Hirchak KA; Amiri S; Kordas G; Oluwoye O; Lyons AJ; Bajet K; Hahn JA; McDonell MG; Campbell ANC; Venner K
    Subst Abuse Treat Prev Policy; 2022 May; 17(1):41. PubMed ID: 35614487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid Prescribing Rates in Nonmetropolitan and Metropolitan Counties Among Primary Care Providers Using an Electronic Health Record System - United States, 2014-2017.
    García MC; Heilig CM; Lee SH; Faul M; Guy G; Iademarco MF; Hempstead K; Raymond D; Gray J
    MMWR Morb Mortal Wkly Rep; 2019 Jan; 68(2):25-30. PubMed ID: 30653483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buprenorphine waiver uptake among nurse practitioners and physician assistants: The role of existing waivered prescriber supply.
    Auty SG; Stein MD; Walley AY; Drainoni ML
    J Subst Abuse Treat; 2020 Aug; 115():108032. PubMed ID: 32600629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.